Dr Gerald M Sacks opines that there is an increasing acceptance of
the use of peripherally acting µ-opioid receptor antagonists for
the treatment of Opioid-Induced Constipation. The health care
professionals need to be comfortable discussing the adverse
effects of the medications in order to prevent the development of
OIC.
Comments
Post a Comment